Ayvakit Approved to Treat GIST With PDGFRA Exon 18 Mutation
Drug is first specifically approved for GISTs harboring PDGFRA exon 18 mutation
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, FDA Approvals, Source Type: news
More News: Cancer & Oncology | Gastrointestinal Stromal Tumour (GIST)